News
PENZBERG, Germany--(BUSINESS WIRE)-- The new xCELLigence RTCA HT Instrument from Roche (SWX:RO) (SWX:ROG) (Pink Sheets:RHHBY) rounds out the Diagnostics Applied Science’s portfolio in real-time cell ...
The new xCELLigence System RTCA HT Instrument from Roche Diagnostics rounds out the company's portfolio in real-time cell analysis with a high-throughput product. The new instrument merges the ...
The recently developed xCELLigence RTCA HT Instrument from Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) now allows to perform fully-automated impedance screens for GPCRs and other targets in ...
Instrument Seeks to Advance Ligand-Gated Aspect of Critically Important Field The first decade of the 21st century has delivered an extraordinary range of new technologies with relevance to early ...
CyteFinder HT complements RareCyte's existing ground-breaking CyteFinder instrument with integrated CytePicker ® module, combining dual-slide loading with superb single-cell retrieval to enable ...
The new xCELLigence RTCA HT Instrument from Roche rounds out the Diagnostics Applied Science’s portfolio in real-time cell analysis with a high-throughput product. The new instrument merges the power ...
PENZBERG, Germany--(BUSINESS WIRE)-- The new xCELLigence RTCA HT Instrument from Roche (SWX:RO) (SWX:ROG) (Pink Sheets:RHHBY) rounds out the Diagnostics Applied Science’s portfolio in real-time cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback